Press Release / Events / Trade Shows / 18th International Conference on Metabolomics and Proteomics

18th International Conference on Metabolomics and Proteomics

Crowd Reviews Partnered with Pulsus to Announce: Unleash the Enigma in Cardiology/ Heart Diseases through Metabolomics 2020
Pulsus Group hosts the 18th International Conference on Metabolomics and Proteomics (Metabolomics 2020) that discusses the new paradigm approach to probe every single element in Metabolomics/ Metabolism. Metabolomics 2020 focuses on many interactive scientific sessions on different types of Blood disorders and Cancers as well as various diagnostic and therapeutic advancements in this field. It also provides an opportunity to showcase your ingenuity to the world. Metabolomics 2020 will be organized around the theme “New Innovations & Novel Perspective on Metabolomics” on October 21- 22, 2020 at Frankfurt, Germany

The major focus on the Conference includes about new mechanisms for targeting specific Proteins in Blood Stream, Latest uses of Lipid in Medicine, Advances in Metabolomics/ Proteomics, Emerging trends in Stem Cell research, Advancements in Diagnostic & Therapeutic areas of Metabolomics, Future directions in Pediatric Metabolism/ Metabolic Diseases and many more.

The attendees of the Congress will enjoy special events and lectures featuring expertise in the field. It is a perfect platform for Scientists and Researchers organizers Directors of Biochemistry department, Hospitals and Healthcare professionals, Metabolomics Research and Development (R&D) Companies, Metabolomics Instrumentation Technology Product Manufacturers, Metabolomics Industry Consulting Firms, Pharmaceutical companies, Genetics Associations and Societies, Doctors, Academic researchers, Professors, Business delegates,Young Researchers, Advertising and Promotion Agency Executives, Medical & Pharmaceutical Companies, Biomedical Research organizations, societies and associations, Students & Delegates from biomedical and healthcare sectors to explore every single element in Metabolomics/ Metabolomic Diseases. Metabolomic-2020 will also provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation, B2B and Scientific Meetings.

All the papers to be presented in Metabolomics 2020 will be published in Biochemistry & Molecular Biology Journal, Metabolomics: Open Access, Journal of Metabolic Syndrome.

Conference Highlights:
• 100+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 30+ Plenary Speakers
• 5+ Exhibitors
• 18 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings

Statistics:
• Only 45% of the global blood supply is collected in developing countries, which are home to more than 80% of the world’s population.
• 41 out of 148 countries (28%) that provided data on screening for transfusion-transmissible infections including HIV, hepatitis B and C, and syphilis were not able to screen all donated blood for one or more of these infections.
•Metabolism Failure is often considered a disease of affluence, but about 70% of Metabolomic Diseases deaths occur in low- and middle-income countries.
• A 2012 study in The Lancet Metabolism predicted that from 2008-2030, Metabolomic Diseases incidence will rise 75 percent globally and will double in the least developed countries.
• Sickle cell disease (SCD) affects millions of people throughout the world and is particularly common among those whose ancestors came from sub-Saharan Africa; Spanish-speaking regions in the Western Hemisphere (South America, the Caribbean, and Central America); Saudi Arabia; India; and Mediterranean countries such as Turkey, Greece, and Italy.
• Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia A each year.

If you are interested to know more about the Congress,
Contact: Shyna Dion
Tel.: +44-203-769-1778
Email: metabolomics@meetingsnexpo.com, metabolomics@lifescienceconferences.org
Website: https://metabolomics.metabolomicsconference.com